Interaction of Herbal Compounds with Biological Targets: a Case Study with Berberine

Overview

Journal ScientificWorldJournal

Publisher Wiley

Specialty Biology

Date 2012 Dec 6

PMID 23213296

Citations 21

Authors

Xiao-Wu Chen

Yuan Ming Di

Jian Zhang

Zhi-Wei Zhou

Chun Guang Li

Shu-Feng Zhou

Affiliations

Soon will be listed here.

Abstract

Berberine is one of the main alkaloids found in the Chinese herb Huang lian (Rhizoma Coptidis), which has been reported to have multiple pharmacological activities. This study aimed to analyze the molecular targets of berberine based on literature data followed by a pathway analysis using the PANTHER program. PANTHER analysis of berberine targets showed that the most classes of molecular functions include receptor binding, kinase activity, protein binding, transcription activity, DNA binding, and kinase regulator activity. Based on the biological process classification of in vitro berberine targets, those targets related to signal transduction, intracellular signalling cascade, cell surface receptor-linked signal transduction, cell motion, cell cycle control, immunity system process, and protein metabolic process are most frequently involved. In addition, berberine was found to interact with a mixture of biological pathways, such as Alzheimer's disease-presenilin and -secretase pathways, angiogenesis, apoptosis signalling pathway, FAS signalling pathway, Hungtington disease, inflammation mediated by chemokine and cytokine signalling pathways, interleukin signalling pathway, and p53 pathways. We also explored the possible mechanism of action for the anti-diabetic effect of berberine. Further studies are warranted to elucidate the mechanisms of action of berberine using systems biology approach.

Citing Articles

N-acetyltransferase 10 affects the proliferation of intrahepatic cholangiocarcinoma and M2-type polarization of macrophages by regulating C-C motif chemokine ligand 2.

Cai T, Dai J, Lin Y, Bai Z, Li J, Meng W J Transl Med. 2024; 22(1):875.

PMID: 39350174 PMC: 11440763. DOI: 10.1186/s12967-024-05664-z.

Formononetin inhibits IgE by huPlasma/PBMCs and mast cells/basophil activation via JAK/STAT/PI3-Akt pathways.

Musa I, Wang Z, Yang N, Li X Front Immunol. 2024; 15:1427563.

PMID: 39221239 PMC: 11363073. DOI: 10.3389/fimmu.2024.1427563.

Antitumor Effect of Berberine Analogs in a Canine Mammary Tumor Cell Line and in Zebrafish Reporters via Wnt/β-Catenin and Hippo Pathways.

Sammarco A, Beffagna G, Sacchetto R, Vettori A, Bonsembiante F, Scarin G Biomedicines. 2023; 11(12).

PMID: 38137538 PMC: 10741123. DOI: 10.3390/biomedicines11123317.

Computational analysis to define efficacy & molecular mechanisms of 7, 4'- Dihydroxyflavone on eosinophilic esophagitis: validation in human esophagus biopsies.

Maskey A, Wang Z, Chen X, Dunkin D, Yang N, Soffer G Front Immunol. 2023; 13:1015437.

PMID: 36591238 PMC: 9797535. DOI: 10.3389/fimmu.2022.1015437.

Berberine Regulation of Cellular Oxidative Stress, Apoptosis and Autophagy by Modulation of mA mRNA Methylation through Targeting the /ERK Pathway in Zebrafish-Hepatocytes.

Zhang M, Liu J, Yu C, Tang S, Jiang G, Zhang J Antioxidants (Basel). 2022; 11(12).

PMID: 36552577 PMC: 9774189. DOI: 10.3390/antiox11122370.

References

Wang Y, Campbell T, Perry B, Beaurepaire C, Qin L . Hypoglycemic and insulin-sensitizing effects of berberine in high-fat diet- and streptozotocin-induced diabetic rats. Metabolism. 2010; 60(2):298-305. DOI: 10.1016/j.metabol.2010.02.005. View

Bruschi G, de Souza C, Fagundes M, Dani M, Goldman M, Morris N . Sensitivity to camptothecin in Aspergillus nidulans identifies a novel gene, scaA+, related to the cellular DNA damage response. Mol Genet Genomics. 2001; 265(2):264-75. DOI: 10.1007/s004380000411. View

Liu J, He C, Zhou K, Wang J, Kang J . Coptis extracts enhance the anticancer effect of estrogen receptor antagonists on human breast cancer cells. Biochem Biophys Res Commun. 2008; 378(2):174-8. PMC: 3454467. DOI: 10.1016/j.bbrc.2008.10.169. View

Al-Masri I, Mohammad M, Tahaa M . Inhibition of dipeptidyl peptidase IV (DPP IV) is one of the mechanisms explaining the hypoglycemic effect of berberine. J Enzyme Inhib Med Chem. 2009; 24(5):1061-6. DOI: 10.1080/14756360802610761. View

Leng S, Lu F, Xu L . Therapeutic effects of berberine in impaired glucose tolerance rats and its influence on insulin secretion. Acta Pharmacol Sin. 2004; 25(4):496-502. View

Li Y, Wang P, Zhuang Y, Lin H, Li Y, Liu L . Activation of AMPK by berberine promotes adiponectin multimerization in 3T3-L1 adipocytes. FEBS Lett. 2011; 585(12):1735-40. DOI: 10.1016/j.febslet.2011.04.051. View

Pan G, Huang Z, Wang G, Fawcett J, Liu X, Zhao X . The antihyperglycaemic activity of berberine arises from a decrease of glucose absorption. Planta Med. 2003; 69(7):632-6. DOI: 10.1055/s-2003-41121. View

Inoue K, Kulsum U, Chowdhury S, Fujisawa S, Ishihara M, Yokoe I . Tumor-specific cytotoxicity and apoptosis-inducing activity of berberines. Anticancer Res. 2005; 25(6B):4053-9. View

Mahata S, Bharti A, Shukla S, Tyagi A, Husain S, Das B . Berberine modulates AP-1 activity to suppress HPV transcription and downstream signaling to induce growth arrest and apoptosis in cervical cancer cells. Mol Cancer. 2011; 10:39. PMC: 3098825. DOI: 10.1186/1476-4598-10-39. View

10.

Zheng C, Han L, Yap C, Xie B, Chen Y . Trends in exploration of therapeutic targets. Drug News Perspect. 2005; 18(2):109-27. DOI: 10.1358/dnp.2005.18.2.886480. View

11.

Asai M, Iwata N, Yoshikawa A, Aizaki Y, Ishiura S, Saido T . Berberine alters the processing of Alzheimer's amyloid precursor protein to decrease Abeta secretion. Biochem Biophys Res Commun. 2006; 352(2):498-502. DOI: 10.1016/j.bbrc.2006.11.043. View

12.

Choi M, Oh J, Kim S, Jung H, Yoo H, Lee Y . Berberine inhibits p53-dependent cell growth through induction of apoptosis of prostate cancer cells. Int J Oncol. 2009; 34(5):1221-30. View

13.

Lee H, Suh J, Kim H, Kim A, Park S, Shin C . Berberine promotes osteoblast differentiation by Runx2 activation with p38 MAPK. J Bone Miner Res. 2008; 23(8):1227-37. DOI: 10.1359/jbmr.080325. View

14.

Li H, Guo L, Jie S, Liu W, Zhu J, Du W . Berberine inhibits SDF-1-induced AML cells and leukemic stem cells migration via regulation of SDF-1 level in bone marrow stromal cells. Biomed Pharmacother. 2008; 62(9):573-8. DOI: 10.1016/j.biopha.2008.08.003. View

15.

Frantz S . Drug discovery: playing dirty. Nature. 2005; 437(7061):942-3. DOI: 10.1038/437942a. View

16.

Chang X, Yan H, Fei J, Jiang M, Zhu H, Lu D . Berberine reduces methylation of the MTTP promoter and alleviates fatty liver induced by a high-fat diet in rats. J Lipid Res. 2010; 51(9):2504-15. PMC: 2918435. DOI: 10.1194/jlr.M001958. View

17.

Barnes P, Powell-Griner E, McFann K, Nahin R . Complementary and alternative medicine use among adults: United States, 2002. Adv Data. 2004; (343):1-19. View

18.

Peng P, Hsieh Y, Wang C, Hsu J, Chou F . Inhibitory effect of berberine on the invasion of human lung cancer cells via decreased productions of urokinase-plasminogen activator and matrix metalloproteinase-2. Toxicol Appl Pharmacol. 2006; 214(1):8-15. DOI: 10.1016/j.taap.2005.11.010. View

19.

Abidi P, Zhou Y, Jiang J, Liu J . Extracellular signal-regulated kinase-dependent stabilization of hepatic low-density lipoprotein receptor mRNA by herbal medicine berberine. Arterioscler Thromb Vasc Biol. 2005; 25(10):2170-6. DOI: 10.1161/01.ATV.0000181761.16341.2b. View

20.

Wajchenberg B . beta-cell failure in diabetes and preservation by clinical treatment. Endocr Rev. 2007; 28(2):187-218. DOI: 10.1210/10.1210/er.2006-0038. View